Kelly Osbourne Has Said That People Only Hate On Weight Loss Drug Ozempic Because They Can’t Afford It, And People With Diabetes Are Begging Her To Understand That That’s The Whole Point

Kelly’s controversial comments come just one month after she said that she has “learned when to shut up and stop talking.”

In recent months, Sharon Osbourne has become one of the most vocal critics of Ozempic, a drug that has recently become popular with celebrities because of its weight loss benefits.

Sharon Osbourne in a white blazer with black lapels and accents, attending a formal event

During an appearance on UK talk show Good Morning Britain in November, Sharon said that Ozempic shouldn’t be available to young people for weight loss because people need to be able to “totally understand” the “side effects” that come with taking it.

Sharon Osbourne in a striped suit with a pearl necklace

But despite all of this, Sharon’s own daughter has heaped praise on Ozempic in a new interview, which has sparked serious backlash.

Sharon and Kelly Osbourne posing at a media event

Needless to say, people have taken to social media to call out what Kelly has said, with extra scrutiny being given to her comment that people are mad because they “can’t afford it.”

Kelly Osbourne, with long purple hair, in a strapless black gown with sheer overlay at the Grammys; she carries a clutch with a recording sleeve design

And the same was being said over on Reddit, where one user wrote, “Yes Kelly, that's why people are complaining, because we're jealous poors. Not at all because the weight loss craze has caused medical shortages for diabetics or anything like that.”

Kelly Osbourne in a yellow floral dress and with blue-gray hair, at a media event

Somebody else referenced another of Kelly’s recently resurfaced scandals: “‘People are jealous because they’re poor’ is a WILD sentiment coming from someone whose career is still recovering from ‘I only support and see immigrants for cleaning my toilet’.”

Kelly Osbourne on The View in 2015

Topics in this article

Skip to footer